@article{2d3b6d7d27874b9e82636893055262a6,
title = "Safety and efficacy of remimazolam in high risk colonoscopy: A randomized trial.",
author = "Rex, \{Douglas K.\} and Raj Bhandari and Lorch, \{Daniel G.\} and Michael Meyers and Frank Schippers and David Bernstein",
note = "Background Procedural sedation of ASA III/IV patients has increased risk. Remimazolam (an ultra-short-acting benzodiazepine) has proven safe and efficient for outpatient colonoscopy sedation. Methods A double-blind, randomized, multi-center, parallel group trial was performed, comparing remimazolam to placebo with an additional open-label arm for midazolam in procedural sedation of 79 ASA III/IV patients undergoing colonoscopy.",
year = "2021",
month = jan,
day = "1",
doi = "10.1016/J.DLD.2020.10.039",
language = "American English",
volume = "53",
journal = "Digestive and Liver Disease",
number = "1",
}